Page last updated: 2024-08-23

levamisole and Blood Diseases

levamisole has been researched along with Blood Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Song, CC; Wen, LY1
Betzler, M; Heimpel, H; Herfarth, C; Lang, M; Lohrmann, HP; Schlag, P; Schreml, W1
Binet, JL; Le Porrier, M1
Gröhn, P; Heinonen, E; Holsti, L; Holsti, P; Klefström, P1
Bonnet, J; Carter, S; Costanzi, JJ; Dabich, L; Dixon, DO; Durie, BG; Files, JC; Rivkin, S; Salmon, SE; Stephens, R1

Reviews

2 review(s) available for levamisole and Blood Diseases

ArticleYear
[Toxic effects of levamisole].
    Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases, 2000, Volume: 18, Issue:3

    Topics: Digestive System Diseases; Drug Eruptions; Female; Hematologic Diseases; Humans; Levamisole; Male; Nervous System Diseases; Urologic Diseases

2000
[Hematology in 1975].
    La Revue du praticien, 1976, May-21, Volume: 26, Issue:29

    Topics: Acute Disease; Anemia, Aplastic; Bone Marrow Cells; Bone Marrow Diseases; Bone Marrow Transplantation; Doxorubicin; Drug Therapy, Combination; Hematologic Diseases; Humans; Leukemia; Levamisole; Lymphocytes; Plicamycin; Radionuclide Imaging; Sarcoma

1976

Trials

3 trial(s) available for levamisole and Blood Diseases

ArticleYear
Adjuvant chemo(immuno-)-therapy of primary breast cancer with adriamycin-cyclophosphamide (and levamisole)--six-year evaluation.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:5

    Topics: Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Levamisole; Mastectomy; Neoplasm Recurrence, Local

1983
Levamisole in the treatment of stage II breast cancer. Five-year follow-up of a randomized double-blind study.
    Cancer, 1985, Jun-15, Volume: 55, Issue:12

    Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Double-Blind Method; Female; Follow-Up Studies; Hematologic Diseases; Humans; Levamisole; Menopause; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Random Allocation

1985
Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:8

    Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Hematologic Diseases; Humans; Levamisole; Melphalan; Multiple Myeloma; Neoplasm Staging; Prednisone; Prognosis; Random Allocation; Vincristine

1986

Other Studies

1 other study(ies) available for levamisole and Blood Diseases

ArticleYear
Levamisole--a cautionary note.
    Lancet (London, England), 1979, Aug-11, Volume: 2, Issue:8137

    Topics: Animals; Hematologic Diseases; Humans; Immunity, Cellular; Levamisole; Lung Neoplasms

1979